HEMATOLOGICAL MALIGNANCY
Clinical trials for HEMATOLOGICAL MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGICAL MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGICAL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune booster after transplant shows promise for blood cancer patients
Disease control CompletedThis early-phase study tested whether giving specially selected donor immune cells (NK cells) soon after a stem cell transplant is safe for people with blood cancers. Seventeen patients received the cells, and researchers monitored for serious side effects within 30 days. The goa…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Institut Paoli-Calmettes • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New melphalan combo shows promise in Half-Matched transplants for blood cancer patients
Disease control CompletedThis study tested a new version of the chemotherapy drug melphalan (EVOMELA) combined with fludarabine and total body irradiation before a half-matched (haploidentical) stem cell transplant in 43 adults with blood cancers like multiple myeloma. The goal was to see if this approac…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Blood 'bath' with light may stop transplant complication
Disease control CompletedThis study tested whether a procedure called extracorporeal photophoresis (ECP) could prevent graft-versus-host disease (GVHD) in 158 people receiving stem cell transplants for blood cancers. ECP involves removing white blood cells, treating them with a light-sensitive drug and U…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: NA • Sponsor: Oslo University Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Fish oil may help kids survive stem cell transplants with fewer side effects
Disease control CompletedThis early-stage trial tested whether a fish oil fat emulsion is safe for children undergoing stem cell transplants for cancer or blood disorders. Twenty children received either fish oil or standard soybean oil fat emulsion through an IV. The goal was to see if fish oil could re…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: PHASE1 • Sponsor: Alexandra N. Carey • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New program helps caregivers of stem cell patients cope better
Symptom relief CompletedThis study tested a support program for people caring for a loved one undergoing a stem cell transplant for blood cancer. The program included 8 online sessions over 12 weeks to teach stress management, coping skills, and communication. 17 caregivers took part, and the study chec…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New study tracks brain changes after stem cell transplants in seniors
Knowledge-focused CompletedThis study looked at how stem cell transplants affect thinking, memory, and daily activities in adults aged 60 to 85 with blood cancer. Researchers measured cognitive function, physical function, and quality of life at several points after transplant. The goal was to understand w…
Matched conditions: HEMATOLOGICAL MALIGNANCY
Sponsor: University of Nebraska • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC